Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome
Article first published online: 7 DEC 2007
Copyright © 2007 Movement Disorder Society
Volume 23, Issue 3, pages 438–440, 15 February 2008
How to Cite
Ben Djebara, M., Worbe, Y., Schüpbach, M. and Hartmann, A. (2008), Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome. Mov. Disord., 23: 438–440. doi: 10.1002/mds.21859
- Issue published online: 25 FEB 2008
- Article first published online: 7 DEC 2007
- Manuscript Accepted: 25 OCT 2007
- Manuscript Received: 20 SEP 2007
- Association Française Syndrome Gilles de la Tourette (AFSGT)
- Fondation Lilly
This article includes supplementary video clips, available online at http://www.interscience.wiley.com/jpages/0885–3185/suppmat .
|mds21859.mpg||12194K||Segment 1. Before treatment with aripiprazole: Our colleague speaks with the patient. While talking about his family, the patient uttered slurs and obscenities steered against women, at the frequency of about 50 words per minute. Segment 2. Twenty-two months later, on aripiprazole: The patient is able to sustain a discussion without coprolalia.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.